XML 357 R14.htm IDEA: XBRL DOCUMENT v3.25.0.1
Investments in Equity and Marketable Securities
 12 Months Ended
Dec. 31, 2024
Investments, Debt and Equity Securities [Abstract]  
Investments in Equity and Marketable Securities Investments in Equity and Marketable Securities
The Company records both marketable securities and equity method investments at fair value. The Company has classified these investments on the Company’s consolidated balance sheets as marketable securities.
The following table summarizes the fair value of the Company’s investment in equity securities as of December 31, 2024 and 2023:
As of December 31,
20242023
Balance, beginning of year$19,933 $3,947 
Investment in publicly traded companies9,798 9,815 
Divestment of publicly traded companies(548)- 
Fair value gain/(loss) on marketable securities(2,711)5,918 
Foreign exchange translation(1,589)253 
Balance, end of year24,883 19,933 
Noncurrent marketable securities(837)(3,047)
Current marketable securities$24,046 $16,886 
During the year ended December 31, 2024, the company purchased an additional 15,158,426 shares and 3,690,372 warrants to purchase common stock of an investment and disposed of 26,308,250 shares related to investments held as of December 31, 2023. As of December 31, 2024, the remaining shares and warrants are carried at a fair value of $24,883. These companies are publicly traded.
During the year ended December 31, 2023, the Company purchased a total of 194,247,800 shares in companies that are publicly traded. As of December 31, 2023, these shares are carried at a fair value of $19,933.
The realized gain on marketable securities sold during the year ended December 31, 2024, was $248. There were no realized gains or losses during the year ended December 31, 2023. The unrealized loss on marketable securities for the year ended December 31, 2024 was $2,711 (year ended December 31, 2023 – $5,918 unrealized gain). These net realized and unrealized gains and losses are recorded in the Consolidated Statements of Operations.